368 related articles for article (PubMed ID: 1510385)
1. Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research Group.
Jenner P; Dexter DT; Sian J; Schapira AH; Marsden CD
Ann Neurol; 1992; 32 Suppl():S82-7. PubMed ID: 1510385
[TBL] [Abstract][Full Text] [Related]
2. Altered mitochondrial function, iron metabolism and glutathione levels in Parkinson's disease.
Jenner P
Acta Neurol Scand Suppl; 1993; 146():6-13. PubMed ID: 8333254
[TBL] [Abstract][Full Text] [Related]
3. Oxidative mechanisms in nigral cell death in Parkinson's disease.
Jenner P
Mov Disord; 1998; 13 Suppl 1():24-34. PubMed ID: 9613715
[TBL] [Abstract][Full Text] [Related]
4. What process causes nigral cell death in Parkinson's disease?
Jenner P
Neurol Clin; 1992 May; 10(2):387-403. PubMed ID: 1584181
[TBL] [Abstract][Full Text] [Related]
5. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia.
Sian J; Dexter DT; Lees AJ; Daniel S; Agid Y; Javoy-Agid F; Jenner P; Marsden CD
Ann Neurol; 1994 Sep; 36(3):348-55. PubMed ID: 8080242
[TBL] [Abstract][Full Text] [Related]
6. Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease.
Dexter DT; Sian J; Rose S; Hindmarsh JG; Mann VM; Cooper JM; Wells FR; Daniel SE; Lees AJ; Schapira AH
Ann Neurol; 1994 Jan; 35(1):38-44. PubMed ID: 8285590
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress and Parkinson's disease.
Owen AD; Schapira AH; Jenner P; Marsden CD
Ann N Y Acad Sci; 1996 Jun; 786():217-23. PubMed ID: 8687021
[TBL] [Abstract][Full Text] [Related]
8. Why are nigral catecholaminergic neurons more vulnerable than other cells in Parkinson's disease?
Hirsch EC
Ann Neurol; 1992; 32 Suppl():S88-93. PubMed ID: 1510386
[TBL] [Abstract][Full Text] [Related]
9. Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease.
Pearce RK; Owen A; Daniel S; Jenner P; Marsden CD
J Neural Transm (Vienna); 1997; 104(6-7):661-77. PubMed ID: 9444566
[TBL] [Abstract][Full Text] [Related]
10. Understanding cell death in Parkinson's disease.
Jenner P; Olanow CW
Ann Neurol; 1998 Sep; 44(3 Suppl 1):S72-84. PubMed ID: 9749577
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases.
Gu M; Owen AD; Toffa SE; Cooper JM; Dexter DT; Jenner P; Marsden CD; Schapira AH
J Neurol Sci; 1998 Jun; 158(1):24-9. PubMed ID: 9667773
[TBL] [Abstract][Full Text] [Related]
12. Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study.
Dexter DT; Holley AE; Flitter WD; Slater TF; Wells FR; Daniel SE; Lees AJ; Jenner P; Marsden CD
Mov Disord; 1994 Jan; 9(1):92-7. PubMed ID: 8139611
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress in Parkinson's disease and other neurodegenerative disorders.
Jenner P
Pathol Biol (Paris); 1996 Jan; 44(1):57-64. PubMed ID: 8734302
[TBL] [Abstract][Full Text] [Related]
14. The oxidant stress hypothesis in Parkinson's disease: evidence supporting it.
Fahn S; Cohen G
Ann Neurol; 1992 Dec; 32(6):804-12. PubMed ID: 1471873
[TBL] [Abstract][Full Text] [Related]
15. Clues to the mechanism underlying dopamine cell death in Parkinson's disease.
Jenner P
J Neurol Neurosurg Psychiatry; 1989 Jun; Suppl(Suppl):22-8. PubMed ID: 2666576
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress and the pathogenesis of Parkinson's disease.
Jenner P; Olanow CW
Neurology; 1996 Dec; 47(6 Suppl 3):S161-70. PubMed ID: 8959985
[TBL] [Abstract][Full Text] [Related]
17. Presymptomatic detection of Parkinson's disease.
Jenner P
J Neural Transm Suppl; 1993; 40():23-36. PubMed ID: 8294898
[TBL] [Abstract][Full Text] [Related]
18. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
[TBL] [Abstract][Full Text] [Related]
19. Metals, oxidative stress and neurodegenerative disorders.
Jomova K; Vondrakova D; Lawson M; Valko M
Mol Cell Biochem; 2010 Dec; 345(1-2):91-104. PubMed ID: 20730621
[TBL] [Abstract][Full Text] [Related]
20. Stage-dependent nigral neuronal loss in incidental Lewy body and Parkinson's disease.
Dijkstra AA; Voorn P; Berendse HW; Groenewegen HJ; ; Rozemuller AJ; van de Berg WD
Mov Disord; 2014 Sep; 29(10):1244-51. PubMed ID: 24996051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
